Cardiovascular MR is uniquely capable of providing insights in cardiac diseases with preserved ejection fraction. Such conditions are a challenge in clinical cardiology. The session will give information on how to differentiate myocardial injury and how to exploit the unique capabilities of CMR today and in the future.
Clinicians who wish to enhance thier understanding of the routine CMR protocols and who wish to gain exposure to emerging applications. Physicists and engineers, who wish to understand the clinical challenges and to develop ideas to address the missing capabilities of current techniques.
Upon completion of this course, participants should be able to:
- Construct clinical protocols for the differentiation of non-coronary artery disease;
- Differentiate underlying injury in similiar phenotypes; and
- Identify routine and emerging techniques in this field.
CMR in Inflammatory Systemic Disorders
1Department of Cardiovascular Medicine,
Alfred Hospital, Melbourne, Australia, 2BakerIDI
Heart and Diabetes Institute, Melbourne, Australia
Cardiac manifestations are frequently observed in many
inflammatory systemic disorders. Identification of
cardiac involvement is of high clinical importance, as
in many instances a large proportion of the morbidity
and mortality in systemic inflammatory diseases is due
to cardiac complications, which if identified early may
be amenable to therapeutic intervention. In order to
simplify the protean cardiac manifestations observed in
inflammatory systemic disorders, these diseases can be
discussed under the general headings of sarcoidosis,
connective tissue diseases, and hypereosinophilic
CMR for Identification of
Secondary Left Ventricular Hypertrophy
1University College London
CMR in Metabolic Disorders
1University Hospital Munich
Besides particular cardiac disease like congenital heart
disease, ischemic heart disease or myocarditis the heart
can be involved in numerous systemic disease entities.
These include endstage kidney disease, liver cirrhosis,
metabolic syndrome, amyloidosis, autoimmune disorders,
hereditary metabolic defects and malignant disease.
Cardiac involvement can include coronary artery disease,
valvular disease, endocardial, myocardial or pericardial
disorders. Detailed knowledge of the potential cardiac
alterations in systemic disease is key in their accurate
diagnosis and treatment.
CMR in Genetic Disorders
Bernd J. Wintersperger1
1Department of Medical Imaging, University of
Toronto, Toronto, ON, Canada
Continuous discoveries in genome abnormities result in
an ever increasing number of cardiovascular diseases
being considered of genetic cause. High importance is
furthermore emphasis of either heritable disease or
individual mutation caused abnormality. While beyond
assessment of genomics, the versatile toolbox of cardiac
MRI enables detailed insight into subtle phenotypes that
may be linked to changes in genotype (genotype +) and as
such provides insight into a possible clinical course of
a disease. Furthermore, cardiac MRI provides ongoing
excellence in the important aspect of initial diagnosis,
therapy monitoring and identification of possible
complications in a large variety of genetic CV diseases.
Adjournment & Meet the